BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26344101)

  • 1. Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling.
    McCommis KS; Chen Z; Fu X; McDonald WG; Colca JR; Kletzien RF; Burgess SC; Finck BN
    Cell Metab; 2015 Oct; 22(4):682-94. PubMed ID: 26344101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis.
    Gray LR; Sultana MR; Rauckhorst AJ; Oonthonpan L; Tompkins SC; Sharma A; Fu X; Miao R; Pewa AD; Brown KS; Lane EE; Dohlman A; Zepeda-Orozco D; Xie J; Rutter J; Norris AW; Cox JE; Burgess SC; Potthoff MJ; Taylor EB
    Cell Metab; 2015 Oct; 22(4):669-81. PubMed ID: 26344103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes: Important role for MPC complex in hepatic gluconeogenesis.
    Greenhill C
    Nat Rev Endocrinol; 2015 Nov; 11(11):629. PubMed ID: 26391977
    [No Abstract]   [Full Text] [Related]  

  • 4. The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity.
    Rauckhorst AJ; Gray LR; Sheldon RD; Fu X; Pewa AD; Feddersen CR; Dupuy AJ; Gibson-Corley KN; Cox JE; Burgess SC; Taylor EB
    Mol Metab; 2017 Nov; 6(11):1468-1479. PubMed ID: 29107293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of hepatic mitochondrial pyruvate and amino acid metabolism impairs gluconeogenesis and endurance exercise capacity in mice.
    Martino MR; Habibi M; Ferguson D; Brookheart RT; Thyfault JP; Meyer GA; Lantier L; Hughey CC; Finck BN
    Am J Physiol Endocrinol Metab; 2024 Apr; 326(4):E515-E527. PubMed ID: 38353639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the Mitochondrial Pyruvate Carrier by Tolylfluanid.
    Chen Y; McCommis KS; Ferguson D; Hall AM; Harris CA; Finck BN
    Endocrinology; 2018 Feb; 159(2):609-621. PubMed ID: 29126303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for the Mitochondrial Pyruvate Carrier in Mammalian Development Revealed by a Hypomorphic Allelic Series.
    Bowman CE; Zhao L; Hartung T; Wolfgang MJ
    Mol Cell Biol; 2016 Aug; 36(15):2089-104. PubMed ID: 27215380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells.
    Lam WY; Becker AM; Kennerly KM; Wong R; Curtis JD; Llufrio EM; McCommis KS; Fahrmann J; Pizzato HA; Nunley RM; Lee J; Wolfgang MJ; Patti GJ; Finck BN; Pearce EL; Bhattacharya D
    Immunity; 2016 Jul; 45(1):60-73. PubMed ID: 27396958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of substrate utilization by the mitochondrial pyruvate carrier.
    Vacanti NM; Divakaruni AS; Green CR; Parker SJ; Henry RR; Ciaraldi TP; Murphy AN; Metallo CM
    Mol Cell; 2014 Nov; 56(3):425-435. PubMed ID: 25458843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1.
    Li A; Liu Q; Li Q; Liu B; Yang Y; Zhang N
    EBioMedicine; 2018 Aug; 34():243-255. PubMed ID: 30093307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1.
    Lou MD; Li J; Cheng Y; Xiao N; Ma G; Li P; Liu B; Liu Q; Qi LW
    Br J Pharmacol; 2019 Aug; 176(16):2962-2976. PubMed ID: 31166615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic glucose production from L-alanine is absent in perfused liver of diabetic rats.
    Ferraz M; Brunaldi K; Oliveira CE; Bazotte RB
    Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):147-55. PubMed ID: 9090751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reexamination of the role of the cytosolic alanine aminotransferase in hepatic gluconeogenesis.
    Patel TB; Olson MS
    Arch Biochem Biophys; 1985 Aug; 240(2):705-11. PubMed ID: 3927842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of gluconeogenesis in perfused liver of alloxan-diabetic fed rats.
    Akimoto LS; Pedrinho SR; Lopes G; Bazotte RB
    Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):65-77. PubMed ID: 11334372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional expression of the mitochondrial pyruvate carrier.
    Herzig S; Raemy E; Montessuit S; Veuthey JL; Zamboni N; Westermann B; Kunji ER; Martinou JC
    Science; 2012 Jul; 337(6090):93-6. PubMed ID: 22628554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone inhibits mitochondrial pyruvate metabolism and glucose production in hepatocytes.
    Shannon CE; Daniele G; Galindo C; Abdul-Ghani MA; DeFronzo RA; Norton L
    FEBS J; 2017 Feb; 284(3):451-465. PubMed ID: 27987376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart: ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION.
    Vadvalkar SS; Matsuzaki S; Eyster CA; Giorgione JR; Bockus LB; Kinter CS; Kinter M; Humphries KM
    J Biol Chem; 2017 Mar; 292(11):4423-4433. PubMed ID: 28154187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism.
    Perry RJ; Borders CB; Cline GW; Zhang XM; Alves TC; Petersen KF; Rothman DL; Kibbey RG; Shulman GI
    J Biol Chem; 2016 Jun; 291(23):12161-70. PubMed ID: 27002151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose-stimulated insulin secretion.
    Vigueira PA; McCommis KS; Schweitzer GG; Remedi MS; Chambers KT; Fu X; McDonald WG; Cole SL; Colca JR; Kletzien RF; Burgess SC; Finck BN
    Cell Rep; 2014 Jun; 7(6):2042-2053. PubMed ID: 24910426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.